Bertrand Loy - 06 Sep 2022 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role
Director
Signature
/s/ David Sirois, by power of attorney
Issuer symbol
HBIO
Transactions as of
06 Sep 2022
Net transactions value
$0
Form type
4
Filing time
15 Sep 2022, 16:02:15 UTC
Previous filing
29 Aug 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HBIO Common Stock Other $0 -108,715 -100% $0.000000* 0 06 Sep 2022 by The BZH Trust F1, F2
holding HBIO Common Stock 420,624 06 Sep 2022 by Bertrand M. Loy Revocable Trust F3
holding HBIO Common Stock 47,493 06 Sep 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 6, 2022, the Reporting Person transferred 108,715 shares of common stock to the Bertrand M. Loy Revocable Trust.
F2 In addition to the 68,466 shares held by The BZH Trust, as previously reported, this number also includes 29,623 shares previously transferred by the Reporting Person to The BZH Trust in September 2020 and 10,626 shares previously transferred by the Reporting Person to The BZH Trust in May 2022.
F3 Consists of (a) the shares described in footnote (1) above and (b) 311,909 shares of common stock previously reported as being held directly by the Reporting Person.
F4 Consists of 47,493 restricted stock units that will vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders, immediately prior to the commencement of such meeting, and (ii) May 24, 2023.